These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2956231)

  • 21. In vitro activity of RP 74501-RP 74502, a novel streptogramin antimicrobial mixture, against clinical isolates of Legionella species.
    Edelstein PH; Edelstein MA
    Antimicrob Agents Chemother; 1993 Apr; 37(4):908-10. PubMed ID: 8494390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro activity of roxithromycin against respiratory and skin pathogens.
    Pechére JC; Auckenthaler R
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():1-5. PubMed ID: 3501424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.
    DiPersio JR; Krafczyk TL
    Antimicrob Agents Chemother; 1978 Aug; 14(2):274-6. PubMed ID: 697353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibiotic.
    Eliopoulos GM; Reiszner E; Ferraro MJ; Moellering RC
    J Antimicrob Chemother; 1987 Nov; 20(5):671-5. PubMed ID: 2962974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro comparison of roxithromycin and erythromycin against 900 anaerobic bacterial strains.
    Dubreuil L
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():13-9. PubMed ID: 3429381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
    Drabu YJ; Mehtar S; Blakemore PH
    Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of macrolides against organisms responsible for respiratory infection with emphasis on Mycoplasma and Legionella.
    Hara K; Suyama N; Yamaguchi K; Kohno S; Saito A
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():75-80. PubMed ID: 3429389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
    Van Asselt GJ; Sloos JH; Mouton RP; Van Boven CP; Van de Klundert JA
    J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in-vitro activity of clarithromycin and other macrolides against the type strain of Chlamydia pneumoniae (TWAR).
    Ridgway GL; Mumtaz G; Fenelon L
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():43-5. PubMed ID: 1827101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.
    Samra Z; Rosenberg S; Dan M
    J Chemother; 2011 Apr; 23(2):77-9. PubMed ID: 21571622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial activity of roxithromycin: a laboratory evaluation.
    Chantot JF; Bryskier A; Gasc JC
    J Antibiot (Tokyo); 1986 May; 39(5):660-8. PubMed ID: 3733515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of single and combined antibiotics on the growth of Legionella pneumophila using time-kill studies.
    Barker JE; Farrell ID
    J Antimicrob Chemother; 1990 Jul; 26(1):45-53. PubMed ID: 2211446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The susceptibility of anaerobic bacteria to rosamicin, erythromycin and clindamycin and factors affecting the activity of rosamicin.
    Kwok YY; Sutter VL; Oberhammer I; Finegold SM
    J Antimicrob Chemother; 1979 Jan; 5(1):61-6. PubMed ID: 33142
    [No Abstract]   [Full Text] [Related]  

  • 34. In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.
    Rolston KV; LeBlanc B; Ho DH
    J Antimicrob Chemother; 1986 Feb; 17(2):161-3. PubMed ID: 3700283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of DNA probes to antimicrobial susceptibility testing of Legionella pneumophila.
    Reznicek M; Bale M; Pfaller M
    Diagn Microbiol Infect Dis; 1991; 14(1):7-10. PubMed ID: 2013212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro activity of miocamycin compared with four other macrolides and with pristinamycin against Branhamella catarrhalis].
    Suermondt G; Denamur E; Fleuret A; Laurans G; Orfila J
    Pathol Biol (Paris); 1989 May; 37(5):386-9. PubMed ID: 2506513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotics against Mycoplasma associated with bovine mastitis.
    Socci A; Bertoldini G; Marca G; Codazza D
    Arch Vet Ital; 1970 Aug; 21(4):235-43. PubMed ID: 5528194
    [No Abstract]   [Full Text] [Related]  

  • 38. [Actions of macrolide antibiotics on alginate production by Pseudomonas aeruginosa].
    Kobayashi O; Ota M; Watanabe H; Kobayashi H
    Jpn J Antibiot; 1997 Mar; 50 Suppl A():95-101. PubMed ID: 9597455
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro activity of azithromycin against clinical isolates of Legionella species.
    Edelstein PH; Edelstein MA
    Antimicrob Agents Chemother; 1991 Jan; 35(1):180-1. PubMed ID: 1849708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of the antibiotics roxithromycin and erythromycin on the gastro-intestinal ecology of mice.
    Koopman JP; van den Brink ME; Scholten PM; Hectors MP; Nagengast FM
    Z Versuchstierkd; 1987; 30(1-2):79-83. PubMed ID: 3324551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.